• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Theravance Inc

+ Add to Watchlist

THRX:US

26.8000 USD 0.2700 1.00%

As of 17:20:00 ET on 04/24/2014.

Snapshot for Theravance Inc (THRX)

Open: 27.7200 Day's Range: 26.3800 - 27.8400 Volume: 939,239
Previous Close: 27.0700 52wk Range: 26.0400 - 42.9599 1-Yr Rtn: -12.25%

Stock Chart for THRX

No chart data available.
  • THRX:US 26.8000
  • 1D
  • 1M
  • 1Y
27.0700
Interactive THRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.6600
Est. EPS (USD) (12/2014) -0.7600
Est. PEG Ratio -
Market Cap (M USD) 3,017.67
Shares Outstanding (M) 112.56
30 Day Average Volume 1,085,250
Price/Book (mrq) 9.9913
Price/Sale (ttm) 572.5013
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THRX

Theravance Inc., is a biopharmaceutical company. The Company develops small molecule medicines for respiratory disease, bacterial infections, and gastrointestinal disorders.

Rick E WinninghamChairman/CEOMichael W AguiarSenior VP/CFO
Bradford J ShaferSenior VP/Secy/Gen CounselLeonard M BlumSenior Vice President
More Company Profile & Key Executives for THRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil